WEST PHARMACEUTICAL SERVICES INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: West Pharmaceutical Services Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
West Pharmaceutical Services Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $161M, a 9.02% decline year-over-year.
West Pharmaceutical Services Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $571M, a 11.4% decline year-over-year.
West Pharmaceutical Services Inc annual Operating Income (Loss) for 2023 was $676M, a 7.9% decline from 2022.
West Pharmaceutical Services Inc annual Operating Income (Loss) for 2022 was $734M, a 2.43% decline from 2021.
West Pharmaceutical Services Inc annual Operating Income (Loss) for 2021 was $752M, a 84.9% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$571M	$161M	-$16M	-9.02%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-24
Q2 2024	$587M	$126M	-$56.3M	-30.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-25
Q1 2024	$644M	$123M	-$32.5M	-20.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-25
Q4 2023	$676M	$161M	+$31.2M	+24.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-20
Q3 2023	$645M	$177M	-$8.9M	-4.78%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-24
Q2 2023	$654M	$183M	-$45.9M	-20.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-25
Q1 2023	$700M	$155M	-$34.4M	-18.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-25
Q4 2022	$734M	$130M	-$54.3M	-29.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-20
Q3 2022	$788M	$186M	+$4.8M	+2.65%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-26
Q2 2022	$784M	$228M	+$17.1M	+8.09%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-07-27
Q1 2022	$766M	$190M	+$14.1M	+8.03%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-27
Q4 2021	$752M	$184M	+$67.9M	+58.5%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-20
Q3 2021	$684M	$181M	+$82.2M	+82.9%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-27
Q2 2021	$602M	$211M	+$108M	+104%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-07-28
Q1 2021	$495M	$176M	+$87.6M	+99.5%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-28
Q4 2020	$407M	$116M	+$38M	+48.7%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-21
Q3 2020	$369M	$99.2M	+$31.9M	+47.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-28
Q2 2020	$337M	$104M	+$23.1M	+28.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-30
Q1 2020	$314M	$88M	+$17.3M	+24.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-30
Q4 2019	$297M	$78.1M	+$12.3M	+18.7%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-22
Q3 2019	$284M	$67.3M	+$6.5M	+10.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-23
Q2 2019	$278M	$80.5M	+$20.2M	+33.5%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-24
Q1 2019	$258M	$70.7M	+$17.3M	+32.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-24
Q4 2018	$240M	$65.8M	+$5.4M	+8.94%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-23
Q3 2018	$235M	$60.8M	-$2.1M	-3.34%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-29
Q2 2018	$237M	$60.3M	+$18.3M	+43.6%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-29
Q1 2018	$219M	$53.4M	-$7.1M	-11.7%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	$226M	$60.4M	+$7.7M	+14.6%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-24
Q3 2017	$218M	$62.9M	+$11.6M	+22.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-30
Q2 2017	$207M	$42M	-$19.2M	-31.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-31
Q1 2017	$226M	$60.5M	+$30.5M	+102%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08
Q4 2016	$195M	$52.7M	+$7.5M	+16.6%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-28
Q3 2016	$188M	$51.3M	+$54.8M		Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-31
Q2 2016	$133M	$61.2M	+$22.1M	+56.5%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-01
Q1 2016	$111M	$30M	-$17.8M	-37.2%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-05
Q4 2015	$129M	$45.2M	+$600K	+1.35%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-26
Q3 2015	$128M	-$3.5M	-$47.5M	-108%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-31
Q2 2015	$176M	$39.1M	-$15M	-27.7%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-01
Q1 2015	$191M	$47.8M	+$8.5M	+21.6%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-06
Q4 2014	$182M	$44.6M	+$7.7M	+20.9%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-28
Q3 2014	$174M	$44M	+$4.3M	+10.8%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-02
Q2 2014	$170M	$54.1M	+$11.6M	+27.3%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-03
Q1 2014	$158M	$39.3M	-$4M	-9.24%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-06
Q4 2013	$162M	$36.9M	+$5.4M	+17.1%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-26
Q3 2013	$157M	$39.7M	+$13.4M	+51%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-03
Q2 2013	$144M	$42.5M	+$6.9M	+19.4%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-01
Q1 2013	$137M	$43.3M	+$1.6M	+3.84%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-08
Q4 2012	$135M	$31.5M	+$4.6M	+17.1%	Oct 1, 2012	Dec 31, 2012	10-K	2015-02-25
Q3 2012	$131M	$26.3M	+$200K	+0.77%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-04
Q2 2012	$130M	$35.6M	+$7.8M	+28.1%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-05
Q1 2012	$123M	$41.7M	+$12.9M	+44.8%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-06
Q4 2011	$110M	$26.9M	+$20.9M	+348%	Oct 1, 2011	Dec 31, 2011	10-K	2014-02-27
Q3 2011	$88.7M	$26.1M	+$800K	+3.16%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-05
Q2 2011	$87.9M	$27.8M	-$2.7M	-8.85%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-06
Q1 2011	$90.6M	$28.8M	-$100K	-0.35%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-04
Q4 2010	$90.7M	$6M			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-27
Q3 2010		$25.3M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-07
Q2 2010		$30.5M			Apr 1, 2010	Jun 30, 2010	10-Q/A	2011-08-08
Q1 2010		$28.9M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.